Immunovant, Inc. (NASDAQ:IMVT) Q1 2022 Results Earnings Conference Call August 9, 2021 8:00 AM ET Company Participants Pete Salzmann - Chief Executive Officer Frank Torti - Executive Chairperson Conference Call Participants Thomas Smith - SVB Leerink Sam Slutsky - LifeSci Capital Operator Good morning. My name is Melissa, and I will serve as your conference call operator today. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. ...

IMMUNOVANT Corporate Overview November 2020 Forward-looking statements This presentation contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as "may," "might," "will," "expect," "plan," "anticipate," "believe," "estimate," "intend," "future," "potential," "continue" and other similar expressions (as well as other words or expressions referencing future events, co ...